Hikma Pharmaceuticals PLC (HIK)
LSE
1,611.00
+11.00 (+0.69%)
Real-time Data
07:00 AM
Day's Range
1,585.001,630.00
52 wk Range
18.091,865.00
Financial Statements - HIK - Hikma Pharmaceuticals PLC
Revenue
3.34B▲ 7.1%
Net Income
407.00M▲ 12.4%Net Margin 12.2%
EBITDA
857.00M▲ 13.5%
Free Cash Flow
119.00M▼ 63.8%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 3.34B | 3.12B | 2.87B | 1.85B | 2.55B | 2.34B |
| Cost of Goods | 1.90B | 1.71B | 1.48B | 942.81M | 1.25B | 1.14B |
| Gross Profit | 1.44B | 1.41B | 1.39B | 912.59M | 1.30B | 1.20B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 633M | 612M | 610M | 355.30M | 597M | 560M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 519M | 455M | 281M | 171.75M | 544M | 558M |
| Income Tax | 112M | 93M | 89M | 30.96M | 124M | 128M |
| Net Income | 407M | 362M | 192M | 140.79M | 420M | 430M |
| EPS Basic | 1.82 | 1.62 | 0.86 | 0.839 | 1.823 | 1.826 |
| EPS Diluted | 1.81 | 1.61 | 0.85 | 0.836 | 1.807 | 1.811 |
| Basic Shares Outstanding | 220.58M | 221.33M | 220.86M | 165.12M | 296.67M | 303.09M |
| Diluted Shares Outstanding | 220.58M | 221.33M | 220.86M | 165.12M | 296.67M | 303.09M |
| Ebit | 607M | 530M | 354M | 215.24M | 600M | 614M |
| Ebitda | 857M | 755M | 792M | 471.77M | 723M | 655M |
| Net Income Continuous Operations | 519M | 455M | 281M | 171.75M | 544M | 558M |
| Minority Interests | -5M | -3M | -2M | -3M | 1M | 1M |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
